My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 453

    1.

    A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents.

    Piechocki MP.

    BMC Cancer. 2008 Apr 24;8:119.PMID: 18435859 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.

    Piechocki MP, Yoo GH, Dibbley SK, Lonardo F.

    Cancer Res. 2007 Jul 15;67(14):6825-43.PMID: 17638894 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

    Wang X, Wang JP, Rao XM, Price JE, Zhou HS, Lachman LB.

    Breast Cancer Res. 2005;7(5):R580-8. Epub 2005 May 23.PMID: 16168101 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

    Cancer Res. 2006 May 1;66(9):4672-80.PMID: 16651418 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.

    Galiè M, Sorrentino C, Montani M, Micossi L, Di Carlo E, D'Antuono T, Calderan L, Marzola P, Benati D, Merigo F, Orlando F, Smorlesi A, Marchini C, Amici A, Sbarbati A.

    Carcinogenesis. 2005 Nov;26(11):1868-78. Epub 2005 Jun 23.PMID: 15975963 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu.

    Piechocki MP, Yoo GH, Dibbley SK, Amjad EH, Lonardo F.

    Int J Cancer. 2006 Jul 15;119(2):441-54.PMID: 16470840 [PubMed - indexed for MEDLINE]Related articles

    7.

    Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.

    Cancer Res. 2007 Sep 15;67(18):8671-81.PMID: 17875707 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

    Astolfi A, Landuzzi L, Nicoletti G, De Giovanni C, Croci S, Palladini A, Ferrini S, Iezzi M, Musiani P, Cavallo F, Forni G, Nanni P, Lollini PL.

    Am J Pathol. 2005 Apr;166(4):1205-16.PMID: 15793299 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.

    Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P.

    Gene Ther. 1998 Mar;5(3):388-93.PMID: 9614559 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".

    Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R.

    Clin Transl Oncol. 2006 Nov;8(11):812-20.PMID: 17134970 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers.

    Suh KS, Crutchley JM, Koochek A, Ryscavage A, Bhat K, Tanaka T, Oshima A, Fitzgerald P, Yuspa SH.

    Clin Cancer Res. 2007 Jan 1;13(1):121-31.PMID: 17200346 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

    Campbell MJ, Wollish WS, Lobo M, Esserman LJ.

    In Vitro Cell Dev Biol Anim. 2002 Jun;38(6):326-33.PMID: 12513120 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu.

    Piechocki MP, Dibbley SK, Lonardo F, Yoo GH.

    Int J Cancer. 2008 Apr 15;122(8):1722-9.PMID: 18076070 [PubMed - indexed for MEDLINE]Related articles

    14.

    Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.

    Cheema SK, Gobin AS, Rhea R, Lopez-Berestein G, Newman RA, Mathur AB.

    Int J Pharm. 2007 Aug 16;341(1-2):221-9. Epub 2007 Apr 3.PMID: 17499461 [PubMed - indexed for MEDLINE]Related articles

    15.

    Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.

    Guo X, Oshima H, Kitmura T, Taketo MM, Oshima M.

    J Biol Chem. 2008 Jul 11;283(28):19864-71. Epub 2008 May 21.PMID: 18495668 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.

    Chung LW, Hsieh CL, Law A, Sung SY, Gardner TA, Egawa M, Matsubara S, Zhau HE.

    Urology. 2003 Nov;62(5 Suppl 1):44-54. Review.PMID: 14607217 [PubMed - indexed for MEDLINE]Related articles

    17.

    Stroma cells: a novel target of herceptin activity.

    Corsini C, Mancuso P, Paul S, Burlini A, Martinelli G, Pruneri G, Bertolini F.

    Clin Cancer Res. 2003 May;9(5):1820-5.PMID: 12738740 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.

    Peterson NC, Servinsky MD, Christian A, Peng Z, Qiu W, Mann J, Dicello J, Huso DL.

    Carcinogenesis. 2005 Sep;26(9):1542-52. Epub 2005 Apr 28.PMID: 15860508 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line.

    Gurzov EN, Nabha SM, Yamamoto H, Meng H, Scharovsky OG, Bonfil RD.

    BMC Cancer. 2007 Oct 1;7:184.PMID: 17908302 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A novel recombinant fusion toxin targeting HER-2/NEU-over-expressing cells and containing human tumor necrosis factor.

    Rosenblum MG, Horn SA, Cheung LH.

    Int J Cancer. 2000 Oct 15;88(2):267-73. Erratum in: Int J Cancer. 2000 Dec 15;88(6):1009. PMID: 11004679 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity